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Heart rate variability in left ventricular hypertrophy SIR,-Mandawat et al in their paper (Br Heart J 1995;73:139-44) showed that heart rate variability was significantly reduced in patients with left ventricular hypertrophy secondary to hypertension or aortic valve disease. In addition they showed that heart rate variability was not affected by f blocker treatment. However, they made no comment on the effect of other antihypertensive agents such as thiazide diuretics and certain calcium antagonists such as nifedipine which can cause reflex sympathetic activation and hence reduce heart rate variability. Nearly 60% of their patients were taking diuretics. We have recently found in a study of Chinese patients with hypertension that thiazide treatment was associated with reduced heart rate variability assessed by nonspectral and spectral methods, compared with a 4 week control during which potassium replacement treatment alone was given (unpublished). Like Mandawat et al we found a significant reduction in the SD of all NN intervals over 24 (SDNN) ACTA system has been demonstrated to perform better (with improved receiver operating characteristic curves) than the Parsonnet system.9 In this comparison the explanatory components of the Parsonnet and ACTA scoring systems were subjected to multiple logistic regression (MLR) analysis. The MLR package always selected the ACTA items rather than the Parsonnet items. Moreover the subjective elements of the Parsonnet data set ("catastrophic state" and "PTCA crash") were not selected as explanators of increased mortality or prolonged stay in the intensive therapy unit (ITU) in this analysis.
There are other systems available, one of which (from New York State) has recently gained considerable publicity for the claims made for it and the criticism it has received.7 10 This system and the Parsonnet system both contain subjective elements, which in the Parsonnet system are not good explanators of outcome but can be used subjectively to increase the score a patient achieves.
The Parsonnet and New York State data sets confine their outcome analysis to death in hospital, but there are more valuable measures of the process undertaken in different centres. Length of ITU stay (included in the ACTA system), length of hospital stay, and estimated in hospital cost are also important outcomes that can be estimated before cardiac surgery and are valuable both to the patient and to the centre undertaking the surgery.
The data becoming available from this type of observational study are increasingly valuable in addressing the planning needs of healthcare purchasers worldwide. Conclu 
